Piramal Pharma opens in-house sterility testing suite in $85m US expansion
The pharmaceutical company has opened a microbiology laboratory at the company’s Lexington facility that more than triples testing space, ahead of a wider sterile injectable manufacturing expansion due in late 2027
This is a short summary. The full story is published by Cleanroomtechnology.
Read full story at Cleanroomtechnology

